161 related articles for article (PubMed ID: 35228394)
1. Improved Refolding of a Human IgG1 Fc (CH2-CH3) Scaffold from Its Inclusion Body in E. coli by Alkaline Solubilization.
Ishikawa S; Ishikawa H; Sato A
Biol Pharm Bull; 2022; 45(3):284-291. PubMed ID: 35228394
[TBL] [Abstract][Full Text] [Related]
2. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human lactoferrin-Fc fusion with an improved plasma half-life.
Shiga Y; Oshima Y; Kojima Y; Sugimoto A; Tamaki N; Murata D; Takeuchi T; Sato A
Eur J Pharm Sci; 2015 Jan; 67():136-143. PubMed ID: 25433245
[TBL] [Abstract][Full Text] [Related]
4. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
Upadhyay V; Singh A; Jha D; Singh A; Panda AK
Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
[TBL] [Abstract][Full Text] [Related]
5. Solubilization and refolding of bacterial inclusion body proteins.
Singh SM; Panda AK
J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
[TBL] [Abstract][Full Text] [Related]
6. Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice.
Kim JK; Tsen MF; Ghetie V; Ward ES
Scand J Immunol; 1994 Oct; 40(4):457-65. PubMed ID: 7939418
[TBL] [Abstract][Full Text] [Related]
7. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.
Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y
Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371
[TBL] [Abstract][Full Text] [Related]
9. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A.
Wines BD; Powell MS; Parren PW; Barnes N; Hogarth PM
J Immunol; 2000 May; 164(10):5313-8. PubMed ID: 10799893
[TBL] [Abstract][Full Text] [Related]
10. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
[TBL] [Abstract][Full Text] [Related]
11. Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli.
Khan RH; Rao KB; Eshwari AN; Totey SM; Panda AK
Biotechnol Prog; 1998; 14(5):722-8. PubMed ID: 9758661
[TBL] [Abstract][Full Text] [Related]
12. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.
Qi X; Sun Y; Xiong S
Microb Cell Fact; 2015 Feb; 14():24. PubMed ID: 25879903
[TBL] [Abstract][Full Text] [Related]
13. High-level expression of human CH2 domain from the Fc region in Pichia pastoris and preparation of anti-CH2 antibodies.
Oyama K; Ohkuri T; Inoue M; Caaveiro JMM; Ueda T
J Biochem; 2021 Oct; 170(2):289-297. PubMed ID: 33772592
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.
Singh SM; Sharma A; Upadhyay AK; Singh A; Garg LC; Panda AK
Protein Expr Purif; 2012 Jan; 81(1):75-82. PubMed ID: 21964443
[TBL] [Abstract][Full Text] [Related]
15. [Expression of ATR-Fc fusion protein in CHO cells].
Gao LH; Hu XW; Chen W; Xu JJ; Zhao J; Chen HP
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):826-31. PubMed ID: 16285529
[TBL] [Abstract][Full Text] [Related]
16. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
[TBL] [Abstract][Full Text] [Related]
17. Use of capillary electrophoresis-sodium dodecyl sulfate to monitor disulfide scrambled forms of an Fc fusion protein during purification process.
Hapuarachchi S; Fodor S; Apostol I; Huang G
Anal Biochem; 2011 Jul; 414(2):187-95. PubMed ID: 21420378
[TBL] [Abstract][Full Text] [Related]
18. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
19. Optimized protocol for soluble prokaryotic expression, purification and refolding of the human inhibin α subunit, a cysteine rich peptide chain.
Kolivand S; Nazari M; Modarressi MH; Najafabadi MRH; Hemati A; Ghafouri-Fard S; Motevaseli E
Hum Antibodies; 2020; 28(2):131-139. PubMed ID: 31658054
[TBL] [Abstract][Full Text] [Related]
20. Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
Cao M; Cao P; Yan H; Lu W; Ren F; Hu Y; Zhang S
Appl Biochem Biotechnol; 2009 Jun; 157(3):562-74. PubMed ID: 19099209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
